Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes

Drug and Alcohol Dependence
Michael S GordonFrank J Vocci

Abstract

This secondary analysis of a randomized trial examines the association between initiation of buprenorphine treatment prior to, versus post-release, and rearrests during the 12-months following release. Official rearrest data (N = 199) for the 12-months post-release were examined. Four outcomes were measured: (1) rearrested (yes/no), (2) time to rearrest, (3) number of rearrests, and (4) severity of charges (less severe vs. severe). A minority (43.1%) of the sample were rearrested (N = 91). There were no significant differences between study conditions in the proportion of rearrested participants [P = 0.28] nor in the mean number of arrests [P  = 0.15]. Likewise, the condition was not a significant predictor of the hazard of rearrest [p = 0.10]. The mean number of days until rearrest for the in prison vs. post-release buprenorphine conditions were not significantly different (205.8 days (SD  = 104.6) vs. 170.8 days (SD  = 113.1), respectively; P  = 0.13]. Treatment condition was not a significant predictor of the likelihood of rearrest for a severe crime compared to a less severe crime [P  = 0.09]. Despite the parent study finding of higher rates of post-release drug treatment entry in the group assigned to start buprenorphine t...Continue Reading

References

Aug 26, 1998·Substance Use & Misuse·D N Nurco
Aug 16, 2002·Substance Use & Misuse·Mike Hough
Jan 22, 2003·Addiction·Sheila M Bird, Sharon J Hutchinson
Dec 4, 2003·Drug and Alcohol Dependence·Yih-Ing HserM Douglas Anglin
Apr 28, 2004·Australian and New Zealand Journal of Public Health·L M StewartM W Knuiman
Feb 1, 2006·Addiction·Seena FazelHelen Doll
Jan 12, 2007·The New England Journal of Medicine·Ingrid A BinswangerThomas D Koepsell
Apr 3, 2008·Current Opinion in Psychiatry·Manop Kanato
Jul 10, 2008·Criminal Justice and Behavior·Timothy W KinlockKevin E O'Grady
Oct 22, 2008·Drug and Alcohol Dependence·Stephen MaguraAndrew Rosenblum
Feb 25, 2009·The American Journal of Forensic Medicine and Pathology·Clarissa S KrinskyKurt B Nolte
Apr 3, 2009·Journal of Substance Abuse Treatment·Timothy W KinlockKevin E O'Grady
May 16, 2009·Drug and Alcohol Dependence·Robert P SchwartzAshraf Ahmed
Jun 29, 2010·Addiction·Elizabeth L C MerrallSheila M Bird
Feb 8, 2011·Drug and Alcohol Dependence·Ingrid A BinswangerMarc F Stern
Jan 24, 2012·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Michelle McKenzieJosiah D Rich
Sep 12, 2012·Addiction Science & Clinical Practice·Ingrid A BinswangerJohn F Steiner
Sep 28, 2015·Drug and Alcohol Dependence·Frank J VocciJerome H Jaffe
Mar 31, 2016·The New England Journal of Medicine·Joshua D LeeCharles P O'Brien
Jan 21, 2017·Drug and Alcohol Dependence·Michael S GordonFrank J Vocci
Sep 30, 2017·Drug and Alcohol Dependence·Robert P SchwartzJerome H Jaffe

❮ Previous
Next ❯

Citations

Dec 14, 2019·The Cochrane Database of Systematic Reviews·Amanda E PerryKath Wright
Jan 22, 2020·Substance Abuse Treatment, Prevention, and Policy·Tiffany Champagne-LangabeerJames R Langabeer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.